AzTrials
AzTrials

StrokeNCT03005457

Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy

A study testing Hemiparesis Therapy with VR in people with Stroke and Hemiparesis, run by Ohio State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pilot study to assess the feasibility and initial efficacy of therapist-as-consultant, game-based CI therapy. Pre/post study design. Participant received a target of 30 hours game-based motor intervention, 100 hours constraint of the less affected upper extremity, and 5 hours therapist consultation (including… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Hemiparesis, Upper Extremity Dysfunction
What is being tested?
Hemiparesis Therapy with VR
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
Jul 2012to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Provide signed and dated informed consent form
  • Willing to comply with all study procedures and be available for the duration of the study
  • Male or female aged > 17
  • Preserved ability to comprehend English and participate in basic elements of the therapy
  • Community-dwelling
  • Experienced mild to moderate hemiparesis at least six months prior
  • Can independently operate the gaming system (those with severe cognitive impairments can usually achieve this)
  • Corrected vision of at least 20/70 as assessed by their ability to identify game objects on the monitor from 5 feet away

Who cannot join

  • concurrent participation in other experimental upper extremity trials
  • concurrent participation in other outpatient rehabilitation for their upper extremity
  • Botox within the last 3 months (confound)
  • near-normal motor function (9-hole Peg Test score above the 10th percentile of a normative sample)
  • minimal nonuse (Motor Activity Log at baseline >2.5, Accelerometry > 60%)
  • major medical issues that would interfere with study treatments or make intensive rehabilitation difficult to tolerate

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University, 2154 Dodd Hall

    Columbus, Ohio, 43210

Other trials in United States

About this study

Official title: A Low-cost Virtual Reality Gaming Platform for Neurorehabilitation of Hemiparesis

Pilot study to assess the feasibility and initial efficacy of therapist-as-consultant, game-based CI therapy. Pre/post study design. Participant received a target of 30 hours game-based motor intervention, 100 hours constraint of the less affected upper extremity, and 5 hours therapist consultation (including completion of a behavioral contract at the first study visit). Duration of intervention was 10 consecutive weekdays, with pre-treatment and post-treatment testing performed within 1 week prior to and 1 week post-intervention by an independent tester.

Being tested
Hemiparesis Therapy with VR
Medical subject headings
Stroke, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hemiparesis Therapy with VRBehavioural

    An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids

Study groups in NCT03005457
Study groupRoleWhat they receive
StrokeExperimentalNot described
Receives: Behavioral: Hemiparesis Therapy with VR
Hemiparesis otherExperimentalNot described
Receives: Behavioral: Hemiparesis Therapy with VR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Motor Activity Log

    Self-report measure of arm use for daily activities

    Measured: Week 0 and Week 3

  2. Change in Wolf Motor Function Test

    Objective measure of motor function in a laboratory setting

    Measured: Week 0 and Week 3

Secondary outcomes (12)
  1. Kinematic Data

    Kinematic data recorded during game play

    Measured: Week 0 and Week 3

  2. Brief Kinesthesia test

    Clinical Assessment of sensation

    Measured: Week 0 and Week 3

  3. Patient Health Questionnaire

    Measures Depression

    Measured: Week 0 and Week 3

  4. Strok Specific Quality of Life Scale

    Quality of life measurement

    Measured: Week 0 and Week 3

  5. Weschler Adult Intelligence Scale Symbol Seach

    Cognitive processing speed assessment

    Measured: Week 0 and Week 3

  6. Montreal Cognitive Assessment

    Baseline cognitive screen

    Measured: Week 0 and Week 3

  7. Survey

    Survey on satisfaction with the intervention

    Measured: Week 0 and Week 3

  8. Mitt Compliance

    Hours of use

    Measured: Week 0 and Week 3

  9. Total game-play time

    Measured: Week 0 and Week 3

  10. Gestures

    Number of gestures of each type registered in game

    Measured: Week 0 and Week 3

  11. Bilateral activity monitors

    Objective measure of arm use

    Measured: Week 0 and Week 3

  12. Action Research Arm Test (ARAT)

    Asses Changes in Limb Function

    Measured: Week 0 and Week 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2016 (estimated)
  2. Study startJul 2012
  3. Primary completionDec 2014
  4. Study completionDec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03005457
Sponsor's protocol ID
60047824
Status last verified
Dec 2016
First submitted
21 Dec 2016
Last updated
29 Dec 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Will be shared upon publication acceptance.

Publications

  • Kelly KM, Borstad AL, Kline D, Gauthier LV. Improved quality of life following constraint-induced movement therapy is associated with gains in arm use, but not motor improvement. Top Stroke Rehabil. 2018 Oct;25(7):467-474. doi: 10.1080/10749357.2018.1481605. Epub 2018 Sep 22.

    PubMed 30246613

Questions about this trial

What is this clinical trial studying?

A study testing Hemiparesis Therapy with VR in people with Stroke and Hemiparesis, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Motor Activity Log (time frame: Week 0 and Week 3). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03005457, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in